Which type of drug are SNRIs primarily classified as?

SNRIs, or serotonin-norepinephrine reuptake inhibitors, are primarily classified as antidepressants because they are used to treat major depressive disorder and other mood disorders. These medications work by increasing the levels of serotonin and norepinephrine in the brain, which are neurotransmitters associated with mood regulation. By inhibiting the reuptake of these neurotransmitters, SNRIs help to improve mood, alleviate feelings of depression, and enhance overall emotional well-being.

The classification of SNRIs as antidepressants is underscored by their indication in clinical practice, where they are often prescribed for individuals experiencing depression and anxiety disorders. This established use aligns with their pharmacological mechanism, targeting the neurotransmitter systems involved in the pathophysiology of depression.